Shareholders meeting

September 18, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Intimation regarding the proceedings of 28th Annual General Meeting of HealthCare Global Enterprises Limited (“the Company”) Stock Code : BSE – 539787, NSE – HCG Reference : Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023, and last updated on January 30, 2026 (“SEBI Circular”) We would like to inform you that the 28th Annual General Meeting (“AGM”) of the Company was held on Friday, September 18, 2026, at 5:00 p.m. (IST) through Video Conferencing (“VC”)/Other Audio Visual Means (“OAVM”) to transact the business as stated in the Notice dated August 06, 2026, convening the AGM. In this regard, please find enclosed the following: 1. Summary of proceedings of the 28th AGM pursuant to Regulation 30 read with Para A of Part A of Schedule III of Listing Regulations, is annexed herewith as Annexure-A. 2. Detailed information relating to 28th AGM of the Company in accordance with Regulation 30 of Listing Regulations read with the SEBI Circular, is annexed herewith as Annexure-B. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/ You are requested to take the information on record. Thanking You, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary and Compliance Officer. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Annexure – A SUMMARY OF THE PROCEEDINGS OF THE 28TH ANNUAL GENERAL MEETING The 28th AGM of the Members of the Company commenced on Friday, September 18, 2026 at 5:00 p.m. (IST) and concluded at 6.00 p.m. IST, through Video Conferencing ("VC"), in compliance with the applicable provisions of the Companies Act, 2013, the General Circular Nos. 14/2020 dated April 8, 2020, 17/2020 dated April 13, 2020, 20/2020 dated May 05, 2020 and subsequent circulars, the latest being 03/2025 dated September 22, 2025, (“MCA Circulars”) issued by the Ministry of Corporate Affairs and Circular Nos. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated May 12, 2020, Circular no. SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated January 15, 2021, Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62 dated May 13, 2022, Circular No. SEBI/HO/CFD/PoD- 2/P/CIR/2023/4 dated January 05, 2023 and Circular No. SEBI/HO/CFD/CFD-PoD-2/P/CIR/2023/167 dated October 07, 2023 and latest being Circular No. SEBI/HO/CFD/CFD-PoD-2/P/ CIR/2024/133 dated October 03, 2024 (collectively “SEBI Circulars”), issued by the Securities and Exchange Board of India ("SEBI") and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). The following Directors were present: Sl. No Name of the Director Designation 01 Dr. B.S. Ajaikumar Non-Executive Chairman and Chairperson of Corporate Social Responsibility Committee. 02 Dr. Manish Mattoo Executive Director and Chief Executive Officer. 03 Ms. Geetha Mathur Non-Executive Independent Director and Chairperson of Audit Committee. 04 Mr. Rajagopalan Raghavan Non-Executive Independent Director and Chairperson of Nomination and Remuneration Committee. 05 Ms. Simrun Mehta Non-Executive and Non-Independent Director and Chairperson of Stakeholders Relationship Committee and Risk Management Committee. 06 Mr. Pradip Manilal Kanakia Non-Executive Independent Director. 07 Mr. Bijou Kurien Non-Executive Independent Director. 08 Mr. Rajiv Maliwal Non-Executive Independent Director. 09 Mr. Akshay Tanna Non-Executive and Non-Independent Director In attendance: Sl. No Name of the Officials Designation 01 Mr. Sanjeev Kumar Chief Financial Officer 02 Ms. Sunu Manuel Company Secretary and Compliance Officer 03 Mr. Vikash Gupta Partner, B S R & Co. LLP, Statutory Auditors 04 Mr. Venkatesh C Director, B S R & Co. LLP, Statutory Auditors 05 Mr. Pradeep B Kulkarni Partner, V Sreedharan & Associates, Scrutinizer HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Members Present: 110 Members attended the Meeting through video conferencing facility. Pursuant to the Articles of Association of the Company, Dr. B. S. Ajaikumar, Chairman of the Board, occupied the Chair and the requisite quorum being present, commenced the proceedings of the Meeting. The Chairman extended a warm welcome to all Members and introduced the Members of the Board, the Statutory Auditors, Secretarial Auditor and key members of the Management Team present at the Meeting. Thereafter, the Chairman requested Ms. Sunu Manuel, Company Secretary and Compliance Officer to brief the Members regarding the arrangements made for the Meeting. The Company Secretary and Compliance Officer informed the Members that the Company had enabled participation at the AGM through the video conferencing facility provided by KFin Technologies Limited (“KFin Technologies”). Members were also provided with the facility to exercise their voting rights electronically, both through remote e-voting and through e-voting at the AGM in compliance with the provisions of the Companies Act, 2013 and the Listing Regulations. It was further explained that Members attending the Meeting through video conferencing, who had not already cast their votes through remote e-voting, could cast their votes through the Insta-Poll e-voting facility provided during the AGM. The Chairman confirmed that he was satisfied that the Company had taken all feasible measures to ensure wide participation and enable the Members to cast their votes on the business items being transacted. Thereafter, the Chairman addressed the Members and delivered his opening remarks. He provided a comprehensive overview of the global and domestic healthcare landscape, with particular reference to recent developments in oncology. He highlighted the pioneering role played by HCG in transforming cancer care in India by introducing advanced technologies and protocols, which have ensured delivery of quality treatment with superior clinical outcomes. He emphasized the Company’s vision of making oncology care accessible, affordable, and compassionate, and reiterated the principle that cancer must be treated the right way, the first time. Subsequently, Dr. Manish Mattoo, Executive Director and CEO of the Company, addressed the shareholders. He presented key highlights of the Company’s financial performance, operations, and business achievements for the financial year 2025-26. Dr. Manish also elaborated on the strategic initiatives undertaken during the year, including other initiatives aimed at strengthening the Company’s leadership position in oncology care. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P [Showing first 8,000 characters — download PDF for full document]